TrialAdvances in therapy2025

Pharmacokinetics, Pharmacodynamics, Bioavailability, and Immunogenicity of Obexelimab Following Subcutaneous Administration in Healthy Japanese and Non-Japanese Volunteers.

Xiaodong Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.